SEC Form N-PORT · 2026-02-28
GDOC ETF Holdings
Goldman Sachs Future Health Care Equity ETF reported 40 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-02-28
- SEC accession
- 0000940400-26-015180
- Series ID
- S000072296
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| LLY | Eli Lilly & Co. | 12.187829% | 2,755,161.81 | 2,619 NS |
| JNJ | Johnson & Johnson | 8.085075% | 1,827,699.51 | 7,357 NS |
| AZN | AstraZeneca PLC | 6.399197% | 1,446,592.57 | 6,923 NS |
| MRK | Merck & Co., Inc | 5.978521% | 1,351,495.3 | 10,915 NS |
| BSX | Boston Scientific Corporation | 5.800335% | 1,311,214.7 | 17,062 NS |
| TMO | Thermo Fisher Scientific Inc | 4.612706% | 1,042,741.11 | 2,001 NS |
| ISRG | Intuitive Surgical Inc. | 4.46137% | 1,008,530.53 | 2,003 NS |
| GH | Guardant Health Inc | 3.729275% | 843,034.2 | 8,978 NS |
| 7741 | HOYA Corp. | 3.622283% | 818,847.69 | 4,523 NS |
| ARGX | Argenx SE | 3.599521% | 813,702.12 | 1,061 NS |
| COR | Cencora Inc | 3.384611% | 765,119.84 | 2,056 NS |
| ABT | Abbott Laboratories | 3.128285% | 707,175.3 | 6,078 NS |
| LONN | Lonza Group AG | 2.939303% | 664,454.33 | 953 NS |
| A | Agilent Technologies Inc. | 2.904313% | 656,544.42 | 5,409 NS |
| DXCM | DexCom Inc | 2.678852% | 605,577.21 | 8,247 NS |
| ROIV | Roivant Sciences Ltd | 2.224347% | 502,832.5 | 17,375 NS |
| MTD | Mettler-Toledo International Inc | 1.771401% | 400,440.17 | 293 NS |
| APGE | Apogee Therapeutics Inc. | 1.617944% | 365,750 | 5,225 NS |
| DIM | Sartorius Stedim Biotech SA | 1.585594% | 358,436.96 | 1,658 NS |
| IONS | Ionis Pharmaceuticals, Inc. | 1.406476% | 317,945.7 | 3,918 NS |
| QGEN | QIAGEN NV | 1.389854% | 314,188.2 | 6,309 NS |
| RGEN | Repligen Corporation | 1.255078% | 283,720.92 | 2,204 NS |
| INSM | Insmed Inc | 1.219433% | 275,663.18 | 1,846 NS |
| PEN | Penumbra Inc. | 1.142592% | 258,292.5 | 750 NS |
| FTOXX | Goldman Sachs Trust | 1.085648% | 245,420.02 | 245,420.02 PA |
| NTRA | NATERA INC | 1.046373% | 236,541.48 | 1,137 NS |
| XENE | Xenon Pharmaceuticals Inc | 1.031323% | 233,139.39 | 5,393 NS |
| RPRX | Royalty Pharma PLC | 1.009611% | 228,231.19 | 4,939 NS |
| UNH | UnitedHealth Group Inc. | 1.005422% | 227,284.25 | 775 NS |
| CYTK | Cytokinetics Inc | 0.975996% | 220,632.12 | 3,546 NS |
| BBIO | Bridgebio Pharma Inc | 0.916069% | 207,085.2 | 3,115 NS |
| MDGL | Madrigal Pharmaceuticals Inc | 0.890531% | 201,312 | 466 NS |
| RYTM | Rhythm Pharmaceuticals Inc | 0.881938% | 199,369.5 | 2,150 NS |
| CGON | CG Oncology Inc. | 0.82897% | 187,395.6 | 3,187 NS |
| ACLX | Arcellx Inc | 0.816962% | 184,681.17 | 1,623 NS |
| WGS | GeneDx Holdings Corp | 0.58674% | 132,637.44 | 1,664 NS |
| RVMD | Revolution Medicines Inc | 0.523056% | 118,241.18 | 1,159 NS |
| PODD | Insulet Corporation | 0.471274% | 106,535.52 | 432 NS |
| RARE | Ultragenyx Pharmaceuticals Inc | 0.374454% | 84,648.41 | 3,619 NS |
| GPCR | Structure Therapeutics Inc | 0.304232% | 68,774.16 | 1,092 NS |